Agili-C™ is an off the shelf, cell free implant that reproducibly regenerates hyaline cartilage and its underlying subchondral bone in a single-step procedure.
Agili-CTM is CE marked for the treatment of focal articular cartilage and osteochondral defects. In preclinical studies, this innovative and proprietary implant has shown to promote migration, adhesion, proliferation and differentiation of mesenchymal stem cells to simultaneously regenerate both bone and cartilage.
Agili-C™ is a rigid bi-phasic implant composed of biocompatible and biodegradable FDA approved materials. The bone phase of the implant is composed of calcium carbonate in the aragonite crystalline form, a well-known biomaterial that enhances bone formation.